Nifty
Sensex
:
:
23719.30
75415.35
64.60 (0.27%)
231.99 (0.31%)

Pharmaceuticals & Drugs - API

Rating :
74/99

BSE: 532482 | NSE: GRANULES

751.95
22-May-2026
  • Open
  • High
  • Low
  • Previous Close
  •  766.8
  •  771.5
  •  750
  •  764.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  667510
  •  508047958.15
  •  773.2
  •  432.6

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 18,624.42
  • 31.30
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 19,013.49
  • 0.23%
  • 3.66

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 38.02%
  • 5.70%
  • 19.09%
  • FII
  • DII
  • Others
  • 15.31%
  • 13.25%
  • 8.63%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.69
  • 6.72
  • -0.22

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.10
  • 2.02
  • 0.69

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.91
  • -1.81
  • -0.98

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.51
  • 21.86
  • 26.07

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.07
  • 3.32
  • 3.45

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.51
  • 12.16
  • 13.48

Earnings Forecasts:

(Updated: 23-05-2026)
Description
2024
2025
2026
2027
Adj EPS
23.26
29.83
37.66
45.23
P/E Ratio
32.33
25.21
19.97
16.63
Revenue
5293.22
6209.89
7095.89
8185.9
EBITDA
1145
1412.59
1655.29
1986.56
Net Income
578.22
775.73
961.31
1187.5
ROA
P/B Ratio
4.05
3.29
2.65
2.35
ROE
13.9
13.38
13.99
15
FCFF
-191.01
287.3
436.47
952.77
FCFF Yield
-0.99
1.48
2.25
4.92
Net Debt
576.93
465.87
-645.8
-1944.25
BVPS
185.8
228.23
283.23
319.42

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
1,470.61
1,197.43
22.81%
1,387.94
1,137.70
22.00%
1,296.99
966.62
34.18%
1,210.11
1,179.87
2.56%
Expenses
1,118.50
945.07
18.35%
1,079.84
907.40
19.00%
1,018.76
763.30
33.47%
963.39
920.60
4.65%
EBITDA
352.10
252.36
39.52%
308.10
230.29
33.79%
278.23
203.32
36.84%
246.72
259.27
-4.84%
EBIDTM
23.94%
21.07%
22.20%
20.24%
21.45%
21.03%
20.39%
21.97%
Other Income
8.77
1.92
356.77%
-3.64
5.68
-
-1.15
3.25
-
16.34
2.06
693.20%
Interest
32.69
23.98
36.32%
28.69
26.57
7.98%
29.19
25.67
13.71%
23.78
27.02
-11.99%
Depreciation
81.75
63.50
28.74%
73.53
56.61
29.89%
72.02
52.52
37.13%
68.85
52.87
30.23%
PBT
262.36
197.55
32.81%
202.23
152.79
32.36%
175.87
128.38
36.99%
144.53
181.44
-20.34%
Tax
60.79
45.52
33.55%
52.02
35.19
47.83%
45.26
31.15
45.30%
31.89
46.79
-31.84%
PAT
201.57
152.03
32.59%
150.21
117.60
27.73%
130.61
97.23
34.33%
112.64
134.65
-16.35%
PATM
13.71%
12.70%
10.82%
10.34%
10.07%
10.06%
9.31%
11.41%
EPS
8.13
6.27
29.67%
6.19
4.85
27.63%
5.38
4.01
34.16%
4.64
5.56
-16.55%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
5,365.65
4,481.61
4,506.37
4,511.92
3,764.92
3,237.54
2,598.65
2,279.20
1,684.62
1,410.57
1,357.18
Net Sales Growth
19.73%
-0.55%
-0.12%
19.84%
16.29%
24.59%
14.02%
35.29%
19.43%
3.93%
 
Cost Of Goods Sold
1,875.71
1,725.70
2,021.25
2,307.28
1,883.64
1,391.28
1,280.93
1,255.56
896.32
679.63
725.03
Gross Profit
3,489.94
2,755.91
2,485.12
2,204.63
1,881.28
1,846.27
1,317.72
1,023.64
788.30
730.93
632.15
GP Margin
65.04%
61.49%
55.15%
48.86%
49.97%
57.03%
50.71%
44.91%
46.79%
51.82%
46.58%
Total Expenditure
4,180.49
3,536.37
3,650.39
3,598.60
3,043.30
2,382.31
2,073.33
1,895.16
1,406.20
1,111.73
1,081.29
Power & Fuel Cost
-
100.74
100.64
95.69
74.66
68.85
59.74
57.67
48.22
38.67
34.97
% Of Sales
-
2.25%
2.23%
2.12%
1.98%
2.13%
2.30%
2.53%
2.86%
2.74%
2.58%
Employee Cost
-
619.66
550.24
420.35
366.44
324.29
259.04
209.82
165.21
140.19
117.57
% Of Sales
-
13.83%
12.21%
9.32%
9.73%
10.02%
9.97%
9.21%
9.81%
9.94%
8.66%
Manufacturing Exp.
-
469.82
408.01
273.93
298.74
228.39
177.94
157.62
120.84
86.23
65.02
% Of Sales
-
10.48%
9.05%
6.07%
7.93%
7.05%
6.85%
6.92%
7.17%
6.11%
4.79%
General & Admin Exp.
-
279.35
211.99
187.96
134.41
172.28
125.63
99.96
83.05
70.02
62.33
% Of Sales
-
6.23%
4.70%
4.17%
3.57%
5.32%
4.83%
4.39%
4.93%
4.96%
4.59%
Selling & Distn. Exp.
-
297.79
290.63
280.00
247.45
159.80
112.17
91.84
83.08
81.37
67.75
% Of Sales
-
6.64%
6.45%
6.21%
6.57%
4.94%
4.32%
4.03%
4.93%
5.77%
4.99%
Miscellaneous Exp.
-
43.32
67.62
33.38
37.96
37.42
57.88
22.69
9.49
15.61
67.75
% Of Sales
-
0.97%
1.50%
0.74%
1.01%
1.16%
2.23%
1.00%
0.56%
1.11%
0.64%
EBITDA
1,185.15
945.24
855.98
913.32
721.62
855.23
525.32
384.04
278.42
298.84
275.89
EBITDA Margin
22.09%
21.09%
18.99%
20.24%
19.17%
26.42%
20.22%
16.85%
16.53%
21.19%
20.33%
Other Income
20.32
12.92
4.40
14.29
18.22
26.88
36.56
26.68
10.84
9.93
5.62
Interest
114.35
103.24
105.82
55.93
23.21
26.28
27.02
28.46
33.06
32.26
37.07
Depreciation
296.15
225.50
207.33
184.49
158.63
151.46
136.95
105.48
76.20
71.51
58.40
PBT
784.99
629.42
547.23
687.17
558.00
704.36
397.90
276.78
180.00
204.99
186.03
Tax
189.96
158.65
141.92
170.58
145.24
154.91
115.73
89.11
63.40
65.20
61.15
Tax Rate
24.20%
24.03%
25.93%
24.82%
26.03%
21.99%
27.19%
32.20%
35.22%
31.81%
32.87%
PAT
595.03
501.52
405.31
516.60
412.76
549.46
335.40
236.41
132.59
164.52
124.89
PAT before Minority Interest
595.03
501.52
405.31
516.60
412.76
549.46
335.40
236.41
132.59
164.52
124.89
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
11.09%
11.19%
8.99%
11.45%
10.96%
16.97%
12.91%
10.37%
7.87%
11.66%
9.20%
PAT Growth
18.65%
23.74%
-21.54%
25.16%
-24.88%
63.82%
41.87%
78.30%
-19.41%
31.73%
 
EPS
24.01
20.24
16.36
20.85
16.66
22.17
13.54
9.54
5.35
6.64
5.04

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
3,715.58
3,225.54
2,834.91
2,586.54
2,173.27
1,843.72
1,529.47
1,304.18
903.60
661.60
Share Capital
24.25
24.24
24.20
24.80
24.77
25.42
25.42
25.38
22.87
21.67
Total Reserves
3,677.62
3,183.00
2,792.68
2,545.01
2,126.23
1,800.02
1,493.09
1,273.38
878.28
611.13
Non-Current Liabilities
465.99
176.04
254.73
282.83
366.30
485.98
552.63
488.19
187.99
246.62
Secured Loans
311.51
68.97
148.64
233.70
333.81
414.83
478.78
433.13
123.90
183.66
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
6.69
0.00
0.00
0.34
0.55
Long Term Provisions
31.76
37.88
29.26
28.31
24.84
21.50
12.58
7.70
7.25
5.58
Current Liabilities
2,003.16
2,082.29
1,813.50
1,641.60
1,173.10
893.40
896.48
877.91
787.13
654.75
Trade Payables
726.07
749.53
782.13
638.61
541.05
356.88
323.48
274.35
215.98
181.10
Other Current Liabilities
304.61
261.08
193.19
200.85
194.25
153.16
113.60
69.84
93.43
79.21
Short Term Borrowings
922.56
1,054.24
810.88
765.58
409.27
371.69
454.21
525.10
473.83
392.85
Short Term Provisions
49.92
17.45
27.31
36.56
28.53
11.66
5.20
8.62
3.90
1.58
Total Liabilities
6,184.73
5,483.87
4,903.14
4,511.53
3,712.67
3,223.10
2,978.58
2,670.28
1,878.72
1,562.97
Net Block
2,426.47
2,095.62
1,910.92
1,541.17
1,332.00
1,203.97
944.25
776.73
644.34
559.94
Gross Block
3,882.08
3,351.81
2,981.22
2,461.77
2,145.15
1,875.23
1,472.94
1,199.63
983.66
822.98
Accumulated Depreciation
1,455.61
1,256.19
1,070.30
920.59
813.15
671.26
528.69
422.90
339.32
263.05
Non Current Assets
3,069.25
2,578.83
2,328.99
2,006.54
1,715.68
1,594.41
1,696.34
1,483.71
1,050.55
744.97
Capital Work in Progress
440.19
271.70
239.39
356.23
239.08
294.20
495.95
514.52
267.43
76.56
Non Current Investment
22.04
21.52
21.21
19.67
18.99
19.34
210.42
156.56
108.23
70.11
Long Term Loans & Adv.
179.51
190.00
157.47
89.47
125.61
76.89
45.72
35.91
30.56
38.37
Other Non Current Assets
1.04
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
3,115.48
2,905.05
2,574.15
2,504.99
1,997.00
1,518.85
1,282.24
1,186.57
828.16
818.00
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,342.82
1,300.55
1,149.41
978.55
782.18
438.43
384.21
279.95
269.18
253.72
Sundry Debtors
942.22
985.83
948.54
924.95
765.42
662.04
673.54
628.25
417.70
375.35
Cash & Bank
596.38
386.38
312.79
409.46
271.04
283.94
89.04
115.64
49.80
130.29
Other Current Assets
234.06
46.28
49.22
61.67
178.35
134.43
135.45
162.73
91.49
58.65
Short Term Loans & Adv.
180.15
186.00
114.19
130.35
127.61
91.83
98.46
114.09
51.66
48.68
Net Current Assets
1,112.32
822.75
760.65
863.38
823.90
625.45
385.76
308.65
41.03
163.25
Total Assets
6,184.73
5,483.88
4,903.14
4,511.53
3,712.68
3,113.26
2,978.58
2,670.28
1,878.71
1,562.97

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
866.57
439.41
738.75
332.06
432.48
476.19
262.24
-0.65
188.24
151.43
PBT
660.17
547.23
687.17
558.00
704.36
425.64
276.78
180.00
204.99
186.03
Adjustment
344.13
328.80
237.69
176.29
194.43
156.88
149.85
107.45
95.14
92.63
Changes in Working Capital
6.02
-246.32
-10.31
-257.19
-274.95
12.75
-75.94
-230.03
-52.37
-79.70
Cash after chg. in Working capital
1,010.32
629.71
914.55
477.11
623.84
595.27
350.69
57.42
247.77
198.97
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-143.75
-190.30
-175.80
-145.05
-191.37
-119.08
-88.45
-58.07
-59.53
-47.54
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-691.29
-360.16
-191.36
-380.12
-277.13
-160.63
-269.82
-462.31
-326.09
-161.65
Net Fixed Assets
-254.98
-101.04
-104.53
-302.61
-204.42
-124.57
-176.36
-282.01
-249.86
-75.62
Net Investments
-340.13
-264.87
-80.00
-5.00
-146.14
61.07
-431.34
-0.01
13.84
-16.48
Others
-96.18
5.75
-6.83
-72.51
73.43
-97.13
337.88
-180.29
-90.07
-69.55
Cash from Financing Activity
-92.51
7.66
-440.29
190.00
-299.31
-212.85
-17.43
528.62
55.87
85.67
Net Cash Inflow / Outflow
82.77
86.92
107.10
141.94
-143.97
102.70
-25.01
65.66
-81.98
75.44
Opening Cash & Equivalents
381.10
291.56
184.71
41.84
185.93
83.02
108.03
42.37
124.35
54.85
Closing Cash & Equivalent
466.11
381.10
291.56
184.71
41.84
185.93
83.02
108.03
42.37
130.29

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
152.63
132.33
116.38
103.62
86.85
71.80
59.73
51.17
39.40
29.20
ROA
8.60%
7.80%
10.97%
10.04%
15.84%
9.99%
6.64%
5.13%
8.12%
9.03%
ROE
14.52%
13.46%
19.18%
17.49%
27.64%
18.54%
13.32%
10.60%
18.23%
23.53%
ROCE
16.16%
15.66%
19.63%
17.37%
25.42%
17.22%
12.71%
11.09%
16.57%
20.16%
Fixed Asset Turnover
2.06
2.07
1.66
1.63
1.97
1.75
1.78
1.55
1.59
1.66
Receivable days
47.23
53.89
75.78
81.94
65.94
83.34
100.03
112.83
100.84
67.60
Inventory Days
64.75
68.26
86.07
85.35
56.39
51.34
51.03
59.23
66.49
63.11
Payable days
156.05
138.29
112.38
114.29
117.79
58.20
54.96
62.37
64.87
59.99
Cash Conversion Cycle
-44.08
-16.14
49.48
52.99
4.54
76.48
96.10
109.70
102.46
70.72
Total Debt/Equity
0.35
0.38
0.38
0.43
0.39
0.49
0.65
0.75
0.73
1.01
Interest Cover
7.39
6.17
13.29
25.04
27.80
16.75
10.72
6.44
7.36
6.02

News Update:


  • Granules India reports 33% rise in Q4 consolidated net profit
    29th Apr 2026, 15:42 PM

    Consolidated total income of the company increased by 23.35% at Rs 1,479.38 crore for Q4FY26

    Read More
  • Granules India’s arm receives four observations from USFDA
    6th Apr 2026, 10:57 AM

    The observations are related to procedural matters and no data integrity - related observations

    Read More
  • Granules India’s arm receives VAI classification for Telangana facility
    1st Apr 2026, 09:59 AM

    The inspection is now closed, and no regulatory action has been recommended

    Read More
  • Granules India’s arm gets EIR with NAI status for packaging facility in US
    5th Mar 2026, 14:12 PM

    The FDA inspection was conducted at the company’s packaging facility in Manassas, Virginia, from December 1 to 3, 2025

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.